King Pharmaceuticals, Inc. (KG) is at an implied volatility extreme high of 72.32% that is greater than 95.77% of past values prior to 7/19/2010 (Close Price 8.59). On prior close, 7/16/2010, the implied volatility was 52.50% and at the 72.05 percentile. Closing price was 8.37.
Today's News on King Pharmaceuticals, Inc.
Today's News on King Pharmaceuticals, Inc.
King Pharma names Bailey chief commercial officer
[AP] - King Pharmaceuticals Inc. named Jeffrey A. Bailey chief
commercial officer to oversee the company's branded
pharmaceutical business.
King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
Somaxon Strikes Deal with P&G
[Zacks] - Somaxon Pharmaceuticals Inc. has entered into a
co-promotional deal with Procter & Gamble for its insomnia
treatment Silenor.
Stock Option Volatility Trading
A service of Trotter Trading Systems
Sunday, Sep 5, 2010